Literature DB >> 1746267

Psychotic exacerbation attributed to low-dose bromocriptine treatment of galactorrhea and hyperprolactinemia.

A Dorevitch1, R Aronzon, M Stark.   

Abstract

Low-dose bromocriptine administered for antipsychotic drug-induced hyperprolactinemia and galactorrhea precipitated an acute psychotic state in a female patient. Discontinuation of the bromocriptine and increase in antipsychotic dosage resulted in complete remission. We advise caution in the use of bromocriptine especially in patients with a pre-existing psychiatric history and recommend monitoring for changes in mental status when bromocriptine is prescribed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1746267     DOI: 10.3109/00016349109007893

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  5 in total

Review 1.  Antipsychotic Induced Symptomatic Hyperprolactinemia: Are Dopamine Agonists Safe?

Authors:  Unax Lertxundi; Saioa Domingo-Echaburu; Javier Peral; Montserrat García
Journal:  Psychopharmacol Bull       Date:  2011-09-15

2.  Bromocriptine and psychosis: a literature review.

Authors:  A Boyd
Journal:  Psychiatr Q       Date:  1995

3.  Bromocriptine-induced schizophrenia.

Authors:  S A Peter; A Autz; M L Jean-Simon
Journal:  J Natl Med Assoc       Date:  1993-09       Impact factor: 1.798

4.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

5.  Management of antipsychotic-induced hyperprolactinemia.

Authors:  Ashley Tewksbury; Amy Olander
Journal:  Ment Health Clin       Date:  2016-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.